Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Gabay

Showing results (131-140 of 259) with videos related to

Pageof 26
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2017
Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory ResponsesPraxedis Martin, Gaby Palmer, Emiliana Rodriguez, et al.
Arthritis Research|May 16, 2002
Production of interleukin-1 receptor antagonist by human articular chondrocytesGaby Palmer, Pierre-Andre Guerne, Francoise Mezin, et al.
Arthritis Research & Therapy|May 15, 2004
The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytesGaby Palmer, Danielle Burger, Françoise Mezin, et al.
RMD Open|March 21, 2018
Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET studyCem Gabay, Jérôme Msihid, Moshe Zilberstein, et al.
European Journal of Immunology|April 28, 2012
Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitisCéline Lamacchia, Emiliana Rodriguez, Gaby Palmer, et al.
Journal of Clinical Epidemiology|October 31, 2024
Prospective registration of trials: where we are, why, and how we could get betterDenis Mongin, Diana Buitrago-Garcia, Sami Capderou, et al.
Frontiers in Immunology|July 7, 2023
The role of interleukin-18 and interleukin-18 binding protein in K/BxN serum transfer-induced arthritisSebastien Fauteux-Daniel, Laura M Merlo Pich, Charlotte Girard-Guyonvarc'h, et al.
Life Science Alliance|April 30, 2020
IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitisJérémie D Goldstein, Esen Y Bassoy, Assunta Caruso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2014
Severe neutrophil-dominated inflammation and enhanced myelopoiesis in IL-33-overexpressing CMV/IL33 miceDominique Talabot-Ayer, Praxedis Martin, Christian Vesin, et al.
Frontiers in Immunology|May 26, 2023
Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseasesCeline Lamacchia, Denis Mongin, Catherine Juillard, et al.
Pageof 26

Showing results (131-140 of 259) with videos related to

Sort By:
Pageof 26
Journal of Immunology (Baltimore, Md. : 1950)|February 26, 2017
Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory ResponsesPraxedis Martin, Gaby Palmer, Emiliana Rodriguez, et al.
Arthritis Research|May 16, 2002
Production of interleukin-1 receptor antagonist by human articular chondrocytesGaby Palmer, Pierre-Andre Guerne, Francoise Mezin, et al.
Arthritis Research & Therapy|May 15, 2004
The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytesGaby Palmer, Danielle Burger, Françoise Mezin, et al.
RMD Open|March 21, 2018
Identification of sarilumab pharmacodynamic and predictive markers in patients with inadequate response to TNF inhibition: a biomarker substudy of the phase 3 TARGET studyCem Gabay, Jérôme Msihid, Moshe Zilberstein, et al.
European Journal of Immunology|April 28, 2012
Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitisCéline Lamacchia, Emiliana Rodriguez, Gaby Palmer, et al.
Journal of Clinical Epidemiology|October 31, 2024
Prospective registration of trials: where we are, why, and how we could get betterDenis Mongin, Diana Buitrago-Garcia, Sami Capderou, et al.
Frontiers in Immunology|July 7, 2023
The role of interleukin-18 and interleukin-18 binding protein in K/BxN serum transfer-induced arthritisSebastien Fauteux-Daniel, Laura M Merlo Pich, Charlotte Girard-Guyonvarc'h, et al.
Life Science Alliance|April 30, 2020
IL-36 signaling in keratinocytes controls early IL-23 production in psoriasis-like dermatitisJérémie D Goldstein, Esen Y Bassoy, Assunta Caruso, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 16, 2014
Severe neutrophil-dominated inflammation and enhanced myelopoiesis in IL-33-overexpressing CMV/IL33 miceDominique Talabot-Ayer, Praxedis Martin, Christian Vesin, et al.
Frontiers in Immunology|May 26, 2023
Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseasesCeline Lamacchia, Denis Mongin, Catherine Juillard, et al.
Pageof 26